Since TOPO-2α is a prominent target for anti-tumor therapy [28] due to its critical role in tumor cell proliferation, we focused our next experiments to determine whether TOPO-2α gene is a direct transcriptional target of Foxm1. This evidence concerns the gene FOXM1 and neoplasm.